top of page
Search


Intranasal Covid19 vaccine developed by our team approved for emergency use in the Mainland
An intranasal Covid19 vaccine developed by researchers at CVVT and the University of Hong Kong (HKU) in collaboration with Xiamen...

CVVT
Dec 5, 2022


Visit By Alibaba Entrepreneurs Fund
This was an exciting day for our center. We had the honor of welcoming executive and investment representatives from the Alibaba...

CVVT
Nov 16, 2022


10 Researchers from CVVT Recognized as Highly Cited Researchers 2022
CVVT proudly announces that ten of its esteemed researchers have been honored as "Highly Cited Researchers 2022" by Clarivate,...

CVVT
Nov 15, 2022
bottom of page
